Start Date
December 1, 2024
Primary Completion Date
December 2, 2024
Study Completion Date
December 4, 2024
Pimavanserin 34 milligrams (MG) [Nuplazid]
Daily treatment with 34 mg per os for 6 weeks. Followed by a wash-out period up to 14 days, do to the theoretical risk of corrected QT interval (QTc) prolongation. Conventional anti-psychotic treatment will be initiated only upon normal ECG.
Collaborators (1)
Rigshospitalet, Denmark
OTHER
GCP unit, Copenhagen University Hospital
UNKNOWN
ACADIA Pharmaceuticals Inc.
INDUSTRY
Bjorn H. Ebdrup
OTHER